This article, which plays the role of a rejoinder in a thematic dossier on the Health Economic-Industrial Complex, reviews the main text’s four comments, partly accepting and partly contesting them, in different proportions. As a synthesis of the problematizations that motivated the debate and the appreciations, favorable or unfavorable, received from different perspectives, the authors of the problematizing text return to their axis of analysis, but now from the ground traced by their critics.
Keywords:
economic policies; dependency-independence area; pharmaceutical industry; drug production; national pharmaceutical assistance policy